Bioventix Announcements

Stay up to date with our recent press releases, Shareholder meetings and any investor related announcements.

Holding(s) in Company

12 April 2024

TR-1: Notification of major interest in shares. To download this report as a PDF file click here.

Unaudited Interim Results for the six months ended 31 December 2023

25 March 2024

Bioventix plc (“Bioventix” or the “Company”)   Unaudited Interim Results for the six months ended 31 December 2023  …

Director/PDMR Shareholding

29 January 2024

Bioventix plc (“Bioventix” or “the Company”) Director Dealing   Bioventix plc (BVXP), a UK company specialising in the development…

Director/PDMR Shareholding

28 November 2023

Bioventix plc   (“Bioventix” or “the Company”)   Director Dealing    Bioventix plc (BVXP), a UK company specialising in the development…

Holding(s) in Company

16 November 2023

TR-1: Notification of major interest in shares. To download this report as a PDF file click here.

Annual Report 2023 Notice of AGM & Proxy Forms

10 November 2023

Bioventix plc (AIM: BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for…

Holding(s) in Company

7 November 2023

TR-1: Notification of major interest in shares. To download this report as a PDF file click here.

Holding(s) in Company

1 November 2023

TR-1: Notification of major interest in shares. To download this report as a PDF file click here.

Results for the year ended 30 June 2023

30 October 2023

Bioventix plc (BVXP) announces its audited results for the year ended 30 June 2023 Highlights: • Revenue up 9%…

Holding(s) in Company

25 September 2023

TR-1: Notification of major interest in shares. To download this report as a PDF file click here.

Holding(s) in Company

19 September 2023

TR-1: Notification of major interest in shares. To download this report as a PDF file click here.

Holding(s) in Company

24 July 2023

TR-1: Notification of major interest in shares. To download this report as a PDF file click here.